MHA 710 - Healthcare Economics Frequently
Tested Exam Questions With Verified
Multiple Choice and Conceptual Actual 100%
Correct Detailed Answers
Guaranteed Pass!!Current Update!!
1. The standard cut-off for cost per quality-adjusted life year (QALY) used by most
governmental decision makers is set in terms of a multiple of national per capita
income. The value of the threshold is usually what percent of national per capita
income?
A. 200
B. 150
C. 300
D. 250
E. 100 - ANSWER E. 100
2. The direct costs in an economic evaluation include the all the following except
A. hospitalization.
B. medical devices.
C. transportation to and from the physician's office.
D. reduced productivity at work.
E. all of the above. - ANSWER D. reduced productivity at work.
,3. When measuring effectiveness of a treatment, surrogate measures reflect
clinical efficacy and include
a. recurrence of the disease.
b. death.
c. bone-mass density (BMD).
d. hip fractures.
e. scores on standard evaluative exams such as EuroQol or SF-36. - ANSWER C.
bone-mass density (BMD)
4. Which of the following measures of effectiveness is not a surrogate measure?
a. Cholesterol level
b. Blood pressure
c. Tumor size
d. Hip fracture
e. Bone-mass density (BMD) - ANSWER D. Hip fracture
5. The intangible costs associated with reduced quality of life include
a. pain and suffering.
b. lost productivity at work.
c. The cost of home remodeling to accommodate a physical handicap.
d. potential income lost due to premature death.
e. all of the above. - ANSWER A. Pain and suffering
,6. Suppose that you are asked to use the standard time trade-off approach to
measuring quality of life and are given the following information. An individual is
faced with living the remaining 10 years of her life suffering from severe
osteoporosis. She reveals that she would be willing to give up four of those years
to live the remaining six in perfect health. What is the utility of one year in the
chronic health state relative to perfect health?
a. 0.4
b. 0.6
c. 4
d. 6
e. There is not enough information to determine the utility of life in this case. -
ANSWER B. 0.6
7. Researchers estimate QALYs in a number of different ways. One popular
approach is called the
a. probability approach.
b. QoL approach.
c. standard gamble.
d. standard measure of well-being.
e. utility of life approach. - ANSWER C. Standard gamble
8. The standard cut-off for cost per QALY is ______ per capita income.
a. equal to
b. 2 times
c. 3 times
, d. 4 times
e. 5 times - ANSWER a. equal to
9. Cost-effectiveness considerations are more formally integrated into health
policy making in
a. the UK.
b. Australia.
c. Europe.
d. Canada.
e. b, c, and d. - ANSWER e. b, c, and d
10. Steps in performing a cost-effectiveness analysis include all of these EXCEPT
a. ranking the alternative treatment options.
b. prioritizing the alternative treatment options.
c. calculating the ICER between each treatment option and the next most
expensive one.
d. eliminating treatment alternatives that are strictly dominated. - ANSWER b.
prioritizing the alternative treatment options
11. Researchers use cost-of-illness studies to
a. study the burden of a disease.
b. determine the low-cost option to treat a disease.
c. compare two or more treatment options when the medical outcome is
identical.
Tested Exam Questions With Verified
Multiple Choice and Conceptual Actual 100%
Correct Detailed Answers
Guaranteed Pass!!Current Update!!
1. The standard cut-off for cost per quality-adjusted life year (QALY) used by most
governmental decision makers is set in terms of a multiple of national per capita
income. The value of the threshold is usually what percent of national per capita
income?
A. 200
B. 150
C. 300
D. 250
E. 100 - ANSWER E. 100
2. The direct costs in an economic evaluation include the all the following except
A. hospitalization.
B. medical devices.
C. transportation to and from the physician's office.
D. reduced productivity at work.
E. all of the above. - ANSWER D. reduced productivity at work.
,3. When measuring effectiveness of a treatment, surrogate measures reflect
clinical efficacy and include
a. recurrence of the disease.
b. death.
c. bone-mass density (BMD).
d. hip fractures.
e. scores on standard evaluative exams such as EuroQol or SF-36. - ANSWER C.
bone-mass density (BMD)
4. Which of the following measures of effectiveness is not a surrogate measure?
a. Cholesterol level
b. Blood pressure
c. Tumor size
d. Hip fracture
e. Bone-mass density (BMD) - ANSWER D. Hip fracture
5. The intangible costs associated with reduced quality of life include
a. pain and suffering.
b. lost productivity at work.
c. The cost of home remodeling to accommodate a physical handicap.
d. potential income lost due to premature death.
e. all of the above. - ANSWER A. Pain and suffering
,6. Suppose that you are asked to use the standard time trade-off approach to
measuring quality of life and are given the following information. An individual is
faced with living the remaining 10 years of her life suffering from severe
osteoporosis. She reveals that she would be willing to give up four of those years
to live the remaining six in perfect health. What is the utility of one year in the
chronic health state relative to perfect health?
a. 0.4
b. 0.6
c. 4
d. 6
e. There is not enough information to determine the utility of life in this case. -
ANSWER B. 0.6
7. Researchers estimate QALYs in a number of different ways. One popular
approach is called the
a. probability approach.
b. QoL approach.
c. standard gamble.
d. standard measure of well-being.
e. utility of life approach. - ANSWER C. Standard gamble
8. The standard cut-off for cost per QALY is ______ per capita income.
a. equal to
b. 2 times
c. 3 times
, d. 4 times
e. 5 times - ANSWER a. equal to
9. Cost-effectiveness considerations are more formally integrated into health
policy making in
a. the UK.
b. Australia.
c. Europe.
d. Canada.
e. b, c, and d. - ANSWER e. b, c, and d
10. Steps in performing a cost-effectiveness analysis include all of these EXCEPT
a. ranking the alternative treatment options.
b. prioritizing the alternative treatment options.
c. calculating the ICER between each treatment option and the next most
expensive one.
d. eliminating treatment alternatives that are strictly dominated. - ANSWER b.
prioritizing the alternative treatment options
11. Researchers use cost-of-illness studies to
a. study the burden of a disease.
b. determine the low-cost option to treat a disease.
c. compare two or more treatment options when the medical outcome is
identical.
